id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-1523-0001,FDA,FDA-2013-N-1523,"Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act; Request for Nominations",Proposed Rule,Request for Information,2013-12-04T05:00:00Z,2013,12,2013-12-04T05:00:00Z,2014-03-05T04:59:59Z,2014-03-11T01:02:11Z,2013-28980,0,0,09000064814a61e6